Announce Date | 02/20/2025 |
EPS Normalized Actual | $0.4812 (Beat by $0.0312) |
EPS GAAP Actual | $0.4812 (Beat by $0.0312) |
Revenue Actual | $2.6295B |
Revenue Surprise | Beat by $2629.5M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 1.85 | 6.11 | 1.79302 | 1.92738 | 1 |
Dec 2028 | 1.8 | 6.28 | 1.68654 | 1.85328 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0.49 | 0.49 | 2.6295B | 2.93% | 2629.5M |
FQ3 2024 (Sep 2024) | 0.15 | 0.15 | 2.3442B | 2.48% | 2344.2M |
FQ2 2024 (Jun 2024) | 0.059 | 0.059 | 2.288B | -5.16% | 2288M |
FQ1 2024 (Mar 2024) | -0.13 | -0.13 | 2.1848B | -2.95% | 2184.8M |
FQ4 2023 (Dec 2023) | 0.31 | 0.31 | 2.5524B | -3.71% | 2552.4M |
FQ3 2023 (Sep 2023) | -0.15 | -0.15 | 2.286B | -10.02% | 2286M |
FQ2 2023 (Jun 2023) | 0.02 | 0.02 | 2.406B | -8.59% | 2406M |
FQ1 2023 (Mar 2023) | 0 | 0 | 2.2493B | 100% | 2249.3M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Oct 2027) | 0.4422 | -- | 0.37543 | 0.48181 | 2 |
FQ3 2027 (Jul 2027) | 0.3838 | -- | 0.32585 | 0.41818 | 2 |
FQ2 2027 (Jun 2027) | 0.41239 | -- | 0.38685 | 0.42651 | 2 |
FQ1 2027 (Mar 2027) | 0.19025 | -- | 0.17847 | 0.19677 | 2 |
FQ4 2026 (Oct 2026) | 0.40445 | -- | 0.34338 | 0.44068 | 3 |
FQ3 2026 (Jul 2026) | 0.3192 | -- | 0.271 | 0.34779 | 3 |
FQ2 2026 (Jun 2026) | 0.34936 | -- | 0.32772 | 0.36133 | 3 |
FQ1 2026 (Mar 2026) | 0.10402 | -- | 0.09757754 | 0.10758 | 3 |
FQ4 2025 (Oct 2025) | 0.34414 | -42.38 | 0.29218 | 0.37497 | 3 |
FQ3 2025 (Sep 2025) | 0.3423 | 56.18 | 0.31788 | 0.35824 | 2 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Oct 2027) | 1.97B | -- | 1.74B | 2.11B | 2 |
FQ3 2027 (Jul 2027) | 1.92B | -- | 1.7B | 2.05B | 2 |
FQ2 2027 (Jun 2027) | 1.97B | -- | 1.87B | 2.02B | 2 |
FQ1 2027 (Mar 2027) | 1.8B | -- | 1.72B | 1.85B | 2 |
FQ4 2026 (Oct 2026) | 1.89B | -- | 1.67B | 2.02B | 2 |
FQ3 2026 (Jul 2026) | 1.83B | -- | 1.62B | 1.96B | 2 |
FQ2 2026 (Jun 2026) | 1.88B | -- | 1.79B | 1.93B | 2 |
FQ1 2026 (Mar 2026) | 1.72B | -- | 1.64B | 1.77B | 2 |
FQ4 2025 (Oct 2025) | 1.8B | -46.44 | 1.59B | 1.92B | 1 |
FQ3 2025 (Sep 2025) | 1.78B | -31.9 | 1.68B | 1.84B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
2
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0.49 | 0.49 | 100% | |
FQ3 2024 (Sep 2024) | 0.15 | 0.15 | 100% | |
FQ2 2024 (Jun 2024) | 0.059 | 0.059 | 100% | |
FQ1 2024 (Mar 2024) | -0.13 | -0.13 | 100% | |
FQ4 2023 (Dec 2023) | 0.31 | 0.31 | 100% | |
FQ3 2023 (Sep 2023) | -0.15 | -0.15 | 100% | |
FQ2 2023 (Jun 2023) | 0.02 | 0.02 | 100% | |
FQ1 2023 (Mar 2023) | 0 | 0 | NAN% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0B | $2.63B | $2629.5M | 100% |
FQ3 2024 (Sep 2024) | $0B | $2.34B | $2344.2M | 100% |
FQ2 2024 (Jun 2024) | $0B | $2.29B | $2288M | 100% |
FQ1 2024 (Mar 2024) | $0B | $2.18B | $2184.8M | 100% |
FQ4 2023 (Dec 2023) | $0B | $2.55B | $2552.4M | 100% |
FQ3 2023 (Sep 2023) | $0B | $2.29B | $2286M | 100% |
FQ2 2023 (Jun 2023) | $0B | $2.41B | $2406M | 100% |
FQ1 2023 (Mar 2023) | $0B | $2.25B | $2249.3M | 100% |